Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Neurologist 12:171-178, Cree,B., 2006
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006
West Nile Virus Neuroinvasive Disease
Ann Neurol 60:286-300, Davis,L.E.,et al, 2006
Safety and Tolerability of Interferon Beta-1b in Pediatric Multiple Sclerosis
Neurol 66:472-476, Banwell,B.,et al, 2006
Revised Diagnostic Criteria for Neuromyelitis Optica
Neurol 66:1485-1489, Wingerchuk,D.M.,et al, 2006
Diagnostic Evaluation of Clinically Normal Subjects with Chronic hyperCKemia
Neurol 66:1585-1587, Fernandez,C.,et al, 2006
Significance of T2 Lesions in Multiple Sclerosis: A 13-Year Longitudinal Study
Ann Neurol 60:236-242, Rudick,R.A.,et al, 2006
Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006
Interferon beta-1a Treatment in Childhood and Juvenile-Onset Multiple Sclerosis
Neurol 67:511-513, Tenembaum,S.N. &Segura,M.J., 2006
Saccades in Presymptomatic and Early Stages of Huntington Disease
Neurol 67:394-399, Blekher,T.,et al, 2006
Identification of an Oculomotor biomarker of Preclinical Huntington Disease
Neurol 67:485-487, Golding,C.V.P.,et al, 2006
Control of Japanese Encephalitis--Within Our Grasp?
NEJM 355:869-871, Solomon,T., 2006
CSF Tests in the Differential Diagnosis of Cretuzfeldt-Jakob Disease
Neurol 67:637-643, Sanchez-Juan,P.,et al, 2006
Diagnosis of Neurolymphomatosis with FDG PET
Neurol 67:722-723, Rosso,S.M.,et al, 2006
Value of the Oral Glucose Tolerance Test in the Evaluation of Chronic Idiopathic Axonal Polyneuropathy
Arch Neurol 63:1075-1079, Hoffman-Snyder,C.,et al, 2006
Common Misdiagnosis of a Common Neurological Disorder: How Are We Misdiagnosing Essential Tremor?
Arch Neurol 63:1100-1104, Jain,S.,et al, 2006
Creutzfeldt-Jakob Disease: Comparative Analysis of MR Imaging Sequences
AJNR 27:1459-1462, Kallenberg,K.,et al, 2006
Restless Legs Syndrome: Is Treatable But Under-Recognised
BMJ 333:457-458, Medcalf,P. &Bhatia,K.P., 2006
Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy
AJNR 27:1612-1616, Hill,M.E.,et al, 2006
CT Arteriography and Venography in Pulsatile Tinnitus: Preliminary Results
AJNR 27:1635-1638, Krishnan,A.,et al, 2006
Distinguishing Between Stroke and Mimic at the Bedside
Stroke 37:769-775,754, Hand,P.J.,et al, 2006
Interobserver Agreement for the Bedside Clinical Assessment of Suspected Stroke
Stroke 37:776-780, Hand,P.J.,et al, 2006
Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006
Aneurysmal Subarachnoid Hemorrhage
NEJM 354:387-396, Suarez,J.I.,et al, 2006
Multiple Sclerosis in Twins From Continental Italy and Sardinia: A Nationwide Study
Ann Neurol 59:27-34, Ristori,G.,et al, 2006
Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006
Chronic Fatigue Syndrome
Lancet 367:346-355, Prins,J.B.,et al, 2006
Accuracy of Color Duplex Ultrasound Diagnosis of Spontaneous Carotid Dissection Causing Ischemia
Stroke 37:377-381, Benninger,D.H.,et al, 2006
Recent Advances in the Diagnosis and Management of Migraine
BMJ 332:25-29, Goadsby,P.J., 2006
MR IMaging and Angiography of Primary CNS Vasculitis of Childhood
AJNR 27:192-199, Aviv,R.I.,et al, 2006
Multiple-Level Studies Are Needed to Assess the True Value of Diagnostic Tests for Dementia
Arch Neurol 63:142-143,146, Van Gool,W.A., 2006
Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006
Mild Cognitive Impariment is Early-Stage Alzheimer Disease
Arch Neurol 63:15-16, Morris,J.C., 2006
MRI of Clot in Cerebral Venous Thrombosis
Stroke 37:991-995, Idbaih,A.,et al, 2006
The Solitary Enhancing Cerebral Lesion: Can FLAIR Aid the Differentiation Between Glioma and Metastasis
AJNR 27:609-611, Tang,Y.M.,et al, 2006
Practice Parameter: Diagnosis and Prognosis of New Onset Parkinson Disease (An Evidence-Based Review)
Neurol 66:968-975, Suchowersky,O.,et al, 2006
Magnetic Resonance Imaging as a Surrogate Outcome Measure of Disability in Multiple Sclerosis: Have We Been Overly Harsh in Our Assessment?
Ann Neurol 59:597-605, Goodin,D.S., 2006
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should be Treated at the Time of Diagnosis
Arch Neurol 63:614-619, Frohman,E.M.,et al, 2006
Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis
Arch Neurol 63:611-619, Pittock,S.J.,et al, 2006
Adult Onset Subacute Sclerosing Panencephalitis: Clinical Profile of 39 Patients From a Tertiary Care Centre
JNNP 77:630-633, Prashanth,L.K.,et al, 2006
Increase in Multiple Sclerosis Relapse Rate Following in vitro Fertilization
Neurol 66:1280-1281, Laplaud,D.-A.,et al, 2006
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006
Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006
MR Diffusion-Weighted Imaging and Outcome Prediction After Ischemic Stroke
Neurol 66:1159-1163, Hand,P.J.,et al, 2006
Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006
MRI T2 Lesion Burden in Multiple Sclerosis. A Plateauing Relationship with Clinical Disability.
Neurol 66:1384-1389, Li,D.K.B.,et al, 2006
Spontaneous Spinal Cerebrospinal Fluid Leaks and Intracranial Hypotension
JAMA 295:2286-2296, Schievink,W.I., 2006
Diffusion-Weighted MR Imaging Characteristics of an Acute Strokelike Form of Multiple Sclerosis
AJNR 27:1006-1008, Rosso,C.,et al, 2006